GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $33.24 $45.00 Friday, 19th Apr 2024 CRBP stock ended at $39.24. This is 7.42% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 11.37% from a day low at $35.79 to a day high of $39.86.
90 days $6.63 $49.87
52 weeks $3.03 $49.87

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
2021-03-19 $2.17 $2.35 $2.09 $2.35 7 465 947
2021-03-18 $2.27 $2.33 $2.14 $2.16 4 257 082
2021-03-17 $2.09 $2.26 $2.01 $2.22 5 336 841
2021-03-16 $2.36 $2.37 $2.12 $2.18 6 929 008
2021-03-15 $2.41 $2.46 $2.21 $2.27 9 325 638
2021-03-12 $2.22 $2.36 $2.12 $2.33 7 638 274
2021-03-11 $2.18 $2.32 $2.10 $2.32 6 330 879
2021-03-10 $2.13 $2.15 $2.01 $2.11 5 591 075
2021-03-09 $1.92 $2.12 $1.91 $2.08 6 036 262
2021-03-08 $1.87 $1.97 $1.81 $1.86 3 935 875
2021-03-05 $1.89 $1.92 $1.63 $1.87 8 292 728
2021-03-04 $2.15 $2.25 $1.77 $1.88 16 255 423
2021-03-03 $2.32 $2.39 $2.20 $2.22 5 622 370
2021-03-02 $2.42 $2.55 $2.30 $2.33 11 008 282
2021-03-01 $2.30 $2.46 $2.23 $2.40 8 398 801
2021-02-26 $2.29 $2.41 $2.14 $2.18 7 262 540
2021-02-25 $2.46 $2.55 $2.24 $2.31 10 970 185
2021-02-24 $2.44 $2.64 $2.38 $2.48 10 046 770
2021-02-23 $2.30 $2.65 $2.03 $2.53 20 356 512
2021-02-22 $2.91 $3.04 $2.75 $2.76 12 572 708
2021-02-19 $2.85 $3.02 $2.72 $2.92 15 230 738
2021-02-18 $2.80 $3.14 $2.62 $2.80 28 434 867
2021-02-17 $3.05 $3.05 $2.81 $2.90 16 354 913
2021-02-16 $3.10 $3.16 $2.97 $3.05 20 270 420
2021-02-12 $2.98 $3.33 $2.86 $2.99 28 610 726
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT